ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

RPID Rapid Micro Biosystems Inc

0.8375
0.0175 (2.13%)
Last Updated: 15:49:19
Delayed by 15 minutes

Period:

Draw Mode:

Volume 30,566
Bid Price 0.8305
Ask Price 0.8337
News -
Day High 0.845

Low
0.74

52 Week Range

High
1.19

Day Low 0.8286
Company Name Stock Ticker Symbol Market Type
Rapid Micro Biosystems Inc RPID NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.0175 2.13% 0.8375 15:49:19
Open Price Low Price High Price Close Price Prev Close
0.8286 0.8286 0.845 0.82
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
108 30,566 $ 0.8359733 $ 25,552 - 0.74 - 1.19
Last Trade Time Type Quantity Stock Price Currency
15:49:00 729 $ 0.8375 USD

Rapid Micro Biosystems Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
35.7M 42.50M - 22.52M -52.47M -1.23 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Rapid Micro Biosystems News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No RPID Message Board. Create One! See More Posts on RPID Message Board See More Message Board Posts

Historical RPID Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.80680.8690.800.81221229,4640.03073.81%
1 Month0.870.990.780.864941448,477-0.0325-3.74%
3 Months0.931.150.780.938405146,087-0.0925-9.95%
6 Months1.071.180.740.9497235131,110-0.2325-21.73%
1 Year0.9011.190.740.963792281,784-0.0635-7.05%
3 Years22.5027.040.746.95127,213-21.66-96.28%
5 Years22.5027.040.746.95127,213-21.66-96.28%

Rapid Micro Biosystems Description

Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company's flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe. It derives revenue from development, manufacturing, marketing and selling Systems and related LIMS connection software, consumables and services.

Your Recent History

Delayed Upgrade Clock